drugset / Trial / NCT04046900

Vaginal Microbiota Transplant

NCT04046900 ↗

Phase 1/2 Recruiting 62 enrolled Douglas Kwon
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a randomized trial of vaginal microbiome transplant vs. saline placebo to restore a Lactobacillus dominant vaginal microbial community in women with recurrent bacterial vaginosis.

Timeline

Start
2021-04-22
Primary completion
2027-01-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vaginal Microbiome Transplant Unknown — —
Comparator Oral Metronidazole Unknown 500 mg Oral

Indications